A citation-based method for searching scientific literature

Laura C Coates, Christopher T Ritchlin, Laure Gossec, Philip S Helliwell, Proton Rahman, Alexa P Kollmeier, Xie L Xu, May Shawi, Chetan S Karyekar, Christine Contré, Wim Noël, Shihong Sheng, Yanli Wang, Stephen Xu, Philip J Mease. Rheumatology (Oxford) 2022
Times Cited: 1







List of co-cited articles
articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Comparative effectiveness of guselkumab in psoriatic arthritis: results from systematic literature review and network meta-analysis.
Philip J Mease, Iain B McInnes, Lai-Shan Tam, Kiefer Eaton, Steve Peterson, Agata Schubert, Soumya D Chakravarty, Anna Parackal, Chetan S Karyekar, Sandhya Nair,[...]. Rheumatology (Oxford) 2021
19
100

A new approach to defining functional ability in ankylosing spondylitis: the development of the Bath Ankylosing Spondylitis Functional Index.
A Calin, S Garrett, H Whitelock, L G Kennedy, J O'Hea, P Mallorie, T Jenkinson. J Rheumatol 1994
100

Classification criteria for psoriatic arthritis: development of new criteria from a large international study.
William Taylor, Dafna Gladman, Philip Helliwell, Antonio Marchesoni, Philip Mease, Herman Mielants. Arthritis Rheum 2006
100

Development of an ASAS-endorsed disease activity score (ASDAS) in patients with ankylosing spondylitis.
C Lukas, R Landewé, J Sieper, M Dougados, J Davis, J Braun, S van der Linden, D van der Heijde. Ann Rheum Dis 2009
567
100


Axial involvement in psoriatic arthritis: An update for rheumatologists.
Denis Poddubnyy, Deepak R Jadon, Filip Van den Bosch, Philip J Mease, Dafna D Gladman. Semin Arthritis Rheum 2021
9
100

Guselkumab in biologic-naive patients with active psoriatic arthritis (DISCOVER-2): a double-blind, randomised, placebo-controlled phase 3 trial.
Philip J Mease, Proton Rahman, Alice B Gottlieb, Alexa P Kollmeier, Elizabeth C Hsia, Xie L Xu, Shihong Sheng, Prasheen Agarwal, Bei Zhou, Yanli Zhuang,[...]. Lancet 2020
106
100


A Systematic Review With Network Meta-Analysis of the Available Biologic Therapies for Psoriatic Disease Domains.
Tiago Torres, Anabela Barcelos, Paulo Filipe, João Eurico Fonseca. Front Med (Lausanne) 2021
6
100

Group for Research and Assessment of Psoriasis and Psoriatic Arthritis 2015 Treatment Recommendations for Psoriatic Arthritis.
Laura C Coates, Arthur Kavanaugh, Philip J Mease, Enrique R Soriano, Maria Laura Acosta-Felquer, April W Armstrong, Wilson Bautista-Molano, Wolf-Henning Boehncke, Willemina Campbell, Alberto Cauli,[...]. Arthritis Rheumatol 2016
539
100

Real-life efficacy of guselkumab in patients with early psoriatic arthritis.
Ilenia Pantano, Daniele Mauro, Francesca Romano, Alessio Gambardella, Mario Valenti, Davide Simone, Daniela Iacono, Antonio Costanzo, Giuseppe Argenziano, Francesco Ciccia. Rheumatology (Oxford) 2022
6
100

A multi-item Physician Global Assessment scale to assess psoriasis disease severity: validation based on four phase III tofacitinib studies.
Kristina Callis Duffin, Andrew G Bushmakin, Joseph C Cappelleri, Lotus Mallbris, Carla Mamolo. BMC Dermatol 2019
6
100

Guselkumab, an inhibitor of the IL-23p19 subunit, provides sustained improvement in signs and symptoms of active psoriatic arthritis: 1 year results of a phase III randomised study of patients who were biologic-naïve or TNFα inhibitor-experienced.
Christopher T Ritchlin, Philip S Helliwell, Wolf-Henning Boehncke, Enrique R Soriano, Elizabeth C Hsia, Alexa P Kollmeier, Soumya D Chakravarty, Federico Zazzetti, Ramanand A Subramanian, Xie L Xu,[...]. RMD Open 2021
13
100

Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA): updated treatment recommendations for psoriatic arthritis 2021.
Laura C Coates, Enrique R Soriano, Nadia Corp, Heidi Bertheussen, Kristina Callis Duffin, Cristiano B Campanholo, Jeffrey Chau, Lihi Eder, Daniel G Fernández-Ávila, Oliver FitzGerald,[...]. Nat Rev Rheumatol 2022
10
100

Special Article: 2018 American College of Rheumatology/National Psoriasis Foundation Guideline for the Treatment of Psoriatic Arthritis.
Jasvinder A Singh, Gordon Guyatt, Alexis Ogdie, Dafna D Gladman, Chad Deal, Atul Deodhar, Maureen Dubreuil, Jonathan Dunham, M Elaine Husni, Sarah Kenny,[...]. Arthritis Rheumatol 2019
191
100

Influence of Axial Involvement on Clinical Characteristics of Psoriatic Arthritis: Analysis from the Corrona Psoriatic Arthritis/Spondyloarthritis Registry.
Philip J Mease, Jacqueline B Palmer, Mei Liu, Arthur Kavanaugh, Renganayaki Pandurengan, Christopher T Ritchlin, Chitra Karki, Jeffrey D Greenberg. J Rheumatol 2018
49
100

Comparison of remission and low disease activity states with DAPSA, MDA and VLDA in a clinical trial setting in psoriatic arthritis patients: 2-year results from the FUTURE 2 study.
Laura C Coates, Peter Nash, Tore K Kvien, Laure Gossec, Philip J Mease, Lawrence Rasouliyan, Luminita Pricop, Steffen M Jugl, Kunal K Gandhi, Corine Gaillez,[...]. Semin Arthritis Rheum 2020
11
100

Guselkumab in patients with active psoriatic arthritis who were biologic-naive or had previously received TNFα inhibitor treatment (DISCOVER-1): a double-blind, randomised, placebo-controlled phase 3 trial.
Atul Deodhar, Philip S Helliwell, Wolf-Henning Boehncke, Alexa P Kollmeier, Elizabeth C Hsia, Ramanand A Subramanian, Xie L Xu, Shihong Sheng, Prasheen Agarwal, Bei Zhou,[...]. Lancet 2020
108
100


Secukinumab provides sustained PASDAS-defined remission in psoriatic arthritis and improves health-related quality of life in patients achieving remission: 2-year results from the phase III FUTURE 2 study.
L C Coates, D D Gladman, P Nash, O FitzGerald, A Kavanaugh, T K Kvien, L Gossec, V Strand, L Rasouliyan, L Pricop,[...]. Arthritis Res Ther 2018
21
100




EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2019 update.
Laure Gossec, Xenofon Baraliakos, Andreas Kerschbaumer, Maarten de Wit, Iain McInnes, Maxime Dougados, Jette Primdahl, Dennis G McGonagle, Daniel Aletaha, Andra Balanescu,[...]. Ann Rheum Dis 2020
307
100

The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): validation and final selection.
M Rudwaleit, D van der Heijde, R Landewé, J Listing, N Akkoc, J Brandt, J Braun, C T Chou, E Collantes-Estevez, M Dougados,[...]. Ann Rheum Dis 2009
100


Efficacy and safety of guselkumab in biologic-naïve patients with active axial psoriatic arthritis: study protocol for STAR, a phase 4, randomized, double-blinded, placebo-controlled trial.
Dafna D Gladman, Philip J Mease, Paul Bird, Enrique R Soriano, Soumya D Chakravarty, May Shawi, Stephen Xu, Sean T Quinn, Cinty Gong, Evan Leibowitz,[...]. Trials 2022
2
100

Efficacy and Safety of Guselkumab, an Interleukin-23p19-Specific Monoclonal Antibody, Through One Year in Biologic-Naive Patients With Psoriatic Arthritis.
Iain B McInnes, Proton Rahman, Alice B Gottlieb, Elizabeth C Hsia, Alexa P Kollmeier, Soumya D Chakravarty, Xie L Xu, Ramanand A Subramanian, Prasheen Agarwal, Shihong Sheng,[...]. Arthritis Rheumatol 2021
18
100


Treatment guidelines in psoriatic arthritis.
Alexis Ogdie, Laura C Coates, Dafna D Gladman. Rheumatology (Oxford) 2020
57
100

Efficacy and safety of guselkumab in patients with active psoriatic arthritis who are inadequate responders to tumour necrosis factor inhibitors: results through one year of a phase IIIb, randomised, controlled study (COSMOS).
Laura C Coates, Laure Gossec, Elke Theander, Paul Bergmans, Marlies Neuhold, Chetan S Karyekar, May Shawi, Wim Noël, Georg Schett, Iain B McInnes. Ann Rheum Dis 2022
7
100

Determining the Minimally Important Difference in the Clinical Disease Activity Index for Improvement and Worsening in Early Rheumatoid Arthritis Patients.
J R Curtis, S Yang, L Chen, J E Pope, E C Keystone, B Haraoui, G Boire, J C Thorne, D Tin, C A Hitchon,[...]. Arthritis Care Res (Hoboken) 2015
59
100

Development of a health index in patients with ankylosing spondylitis (ASAS HI): final result of a global initiative based on the ICF guided by ASAS.
U Kiltz, D van der Heijde, A Boonen, A Cieza, G Stucki, M A Khan, W P Maksymowych, H Marzo-Ortega, J Reveille, S Stebbings,[...]. Ann Rheum Dis 2015
108
100


Development and validation of the Spondyloarthritis Research Consortium of Canada (SPARCC) Enthesitis Index.
W P Maksymowych, C Mallon, S Morrow, K Shojania, W P Olszynski, R L Wong, J Sampalis, B Conner-Spady. Ann Rheum Dis 2009
169
100

The Epidemiology of Psoriatic Arthritis.
Alexis Ogdie, Pamela Weiss. Rheum Dis Clin North Am 2015
232
100

Long-Term Efficacy and Safety of Guselkumab, a Monoclonal Antibody Specific to the p19 Subunit of Interleukin-23, Through Two Years: Results From a Phase III, Randomized, Double-Blind, Placebo-Controlled Study Conducted in Biologic-Naive Patients With Active Psoriatic Arthritis.
Iain B McInnes, Proton Rahman, Alice B Gottlieb, Elizabeth C Hsia, Alexa P Kollmeier, Xie L Xu, Yusang Jiang, Shihong Sheng, May Shawi, Soumya D Chakravarty,[...]. Arthritis Rheumatol 2022
10
100


Patient global assessment in psoriatic arthritis: a multicenter GRAPPA and OMERACT study.
Alberto Cauli, Dafna D Gladman, Alessandro Mathieu, Ignazio Olivieri, Giovanni Porru, Paul P Tak, Claudia Sardu, Ilona Ujfalussy, Raffaele Scarpa, Antonio Marchesoni,[...]. J Rheumatol 2011
84
100

Disease activity in psoriatic arthritis (PsA): defining remission and treatment success using the DAPSA score.
Monika M Schoels, Daniel Aletaha, Farideh Alasti, Josef S Smolen. Ann Rheum Dis 2016
213
100

Physician's Global Assessment in Psoriatic Arthritis: A Multicenter GRAPPA Study.
Alberto Cauli, Dafna D Gladman, Alessandro Mathieu, Ignazio Olivieri, Giovanni Porru, Paul P Tak, Claudia Sardu, Raffaele Scarpa, Antonio Marchesoni, William J Taylor,[...]. J Rheumatol 2018
7
100

GRAPPA Treatment Recommendations: Updates and Methods.
Arthur Kavanaugh, Laura C Coates, Danielle A van der Windt, Nadia Corp, Enrique R Soriano. J Rheumatol Suppl 2020
7
100

Guidelines of care for the management of psoriasis and psoriatic arthritis: Section 2. Psoriatic arthritis: overview and guidelines of care for treatment with an emphasis on the biologics.
Alice Gottlieb, Neil J Korman, Kenneth B Gordon, Steven R Feldman, Mark Lebwohl, John Y M Koo, Abby S Van Voorhees, Craig A Elmets, Craig L Leonardi, Karl R Beutner,[...]. J Am Acad Dermatol 2008
315
100

A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index.
S Garrett, T Jenkinson, L G Kennedy, H Whitelock, P Gaisford, A Calin. J Rheumatol 1994
100

Guselkumab: the First Selective IL-23 Inhibitor for Active Psoriatic Arthritis in Adults.
Wolf-Henning Boehncke, Nicolo Costantino Brembilla, Michael John Nissen. Expert Rev Clin Immunol 2021
14
100


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.